Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma von IRIE, Reiko F, OLLILA, David W, O'DAY, Steven, MORTON, Donald L

Volltext

IgM Anti-Ganglioside Antibodies Induced by Melanoma Cell Vaccine Correlate with Survival of Melanoma Patients von Takahashi, Takenori, Johnson, Timothy D., Nishinaka, Yumiko, Morton, Donald L., Irie, Reiko F.

Volltext

Anti-Tyrosinase-Related Protein-2 Immune Response in Vitiligo Patients and Melanoma Patients Receiving Active-Specific Immunotherapy von Okamoto, Tetsuro, Fujii, Shigeyuki, Huang, Sharon K.S., Hoon, Dave S.B., Irie, Reiko F., Nizze, Anne J., Morton, Donald L.

Volltext

Regression of Cutaneous Metastatic Melanoma by Intralesional Injection with Human Monoclonal Antibody to Ganglioside GD2 von Irie, Reiko F., Morton, Donald L.

Volltext

Complement-Mediated Anti-HIV-1 Effect Induced by Human IgM Monoclonal Antibody Against Ganglioside GM2 von Wu, Xiaoshan, Okada, Noriko, Momota, Hiroshi, Irie, Reiko F, Okada, Hidechika

Volltext

Cellular immuno-PCR. Detection of a carbohydrate tumor marker von Zhang, Z, Irie, RF, Chi, DD, Hoon, DS

Volltext

Ganglioside GM3:GD3 ratio as an index for the management of melanoma von Ravindranath, Mepur H., Tsuchida, Tetsuya, Morton, Donald L., Irie, Reiko F.

Volltext

Cytotoxic T lymphocytes that recognize decameric peptide sequences of retinoblastoma binding protein 1 (RBP-1) associated with human breast cancer von TAKAHASHI, T, CAO, J, HOON, D. S. B, IRIE, R. F

Volltext

A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A von MORIOKA, N, SZE, L. L, MORTON, D. L, IRIE, R. F

Volltext

Human monoclonal antibody to ganglioside GM2 for melanoma treatment von Irie, R F, Matsuki, T, Morton, D L

Volltext

Interleukin 4 alone and with γ-interferon or α-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas von HOON, D. S. B, OKUN, E, BANEZ, M, IRIE, R. F, MORTON, D. L

Volltext

Gangliosides of Human Melanoma von Tsuchida, Tetsuya, Saxton, Romaine E., Morton, Donald L., Irie, Reiko F.

Volltext

A decapeptide (Gln-Asp-Leu-Thr-Met-Lys-Tyr-Gln-Ile-Phe) from human melanoma is recognized by CTL in melanoma patients von Morioka, N, Kikumoto, Y, Hoon, DS, Morton, DL, Irie, RF

Volltext

An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy von RAVINDRANATH, M. H, MORTON, D. L, IRIE, R. F

Volltext

Identification of a Human Neuroectodermal Tumor Antigen (OFA-I-2) as Ganglioside GD2 von Cahan, Leslie D., Irie, Reiko F., Singh, Rajesh, Cassidenti, Andrew, Paulson, James C.

Volltext

Immunogenicity of melanoma‐associated gangliosides in cancer patients von Tai, Tadashi, Cahan, Leslie D., Tsuchida, Tetsuya, Saxton, Romaine E., Irie, Reiko F., Morton, Donald L.

Volltext

Human IgM Monoclonal Antibody to Ganglioside GM2 and Complement Suppress Virus Propagation in Ex Vivo Cultures of Lymphocytes from HIV-1 Infected Patients von Okada, Noriko, Wu, Xiaoshan, Mizokami, Masashi, Irie, Reiko F., Okada, Hidechika

Volltext

707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma von TAKAHASHI, T, IRIE, R. F, NISHINAKA, Y, HOON, D. S. B

Volltext

Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanoma von MORTON, DONALD L., HOON, DAVE S. B., NIZZE, J. ANNE, FOSHAG, LELAND J., FAMATIGA, ESTELA, WANEK, LESLIE A., CHANG, CINDY, IRIE, REIKO F., GUPTA, RISHAB K., ELASHOFF, ROBERT

Volltext

Gangliosides of human melanoma von Tsuchida, Tetsuya, Saxton, Romaine E., Morton, Donald L., Irie, Reiko F.

Volltext